The Possibility of differentiation between nonalcoholic steatohepatitis and fatty liver in rabbits on Gd-EOB-DTPA-enhanced open-type MRI scans.
OBJECTIVE
We used rabbits to investigate the possibility of differentiating between nonalcoholic steatohepatitis (NASH) and fatty liver (FL) on scans acquired by open-type‒ and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)‒enhanced magnetic resonance imaging (MRI).


METHODS
We divided 15 adult rabbits into three equal groups; they received standard (control group), high-fat (FL) content (FL group), or choline-deficient chow (NASH group). With the animals under general anesthesia we acquired scans on an open 0.3-Tesla MRI system. Signal intensity (SI) was measured before and after contrast administration and defined as SI-pre and SI-post, respectively. Relative SI enhancement (Sr) was calculated using the equation: Sr = (average of three SI-post- minus average of three SI values in no-signal fields)/(average of three SI-pre- minus average of three SI values in no-signal fields) × 100. Maximum Sr (Srmax), the time (in seconds) required to reach Srmax (Tmax), and the difference between Srmax and Sr at 30 minutes (Sr(30m)R) were analyzed.


RESULTS
Srmax was significantly higher in the NASH rabbits than the other two groups (P < .05).


CONCLUSIONS
In rabbits, the Srmax value made it possible to differentiate NASH from normal and fatty liver.
Department of Radiology, Shiga University of Medical Science, Setatsukinowa-cho, Otsu, Japan. akinagasonoda@yahoo.co.jp
Akinaga
A
Sonoda
Norihisa
N
Nitta
Shinich
S
Ohta
Ayumi
A
Nitta-Seko
Keiko
K
Tsuchiya
Yukihiro
Y
Nagatani
Kenichi
K
Mukaisho
Masashi
M
Takahashi
Kiyoshi
K
Murata
D000818:Animals; D003287:Contrast Media; D003937:Diagnosis, Differential; D005234:Fatty Liver / Q000175:diagnosis; D005235:Fatty Liver, Alcoholic / Q000175:diagnosis*; D005240:Feasibility Studies; D005260:Female; D019786:Gadolinium DTPA; D007089:Image Enhancement / Q000379:methods*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D065626:Non-alcoholic Fatty Liver Disease; D011817:Rabbits; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
D003287:Contrast Media; C073590:gadolinium ethoxybenzyl DTPA; D019786:Gadolinium DTPA